[HTML][HTML] Efficacy and safety of acupuncture combined with Xuefu Zhuyu Decoction on major adverse cardiovascular events after percutaneous coronary intervention: A …

Q Ma, Z Cai, L Sui, X Wang - Medicine, 2022 - journals.lww.com
Background: Percutaneous coronary intervention (PCI) is an effective treatment for coronary
heart disease (CHD). With the merits of small trauma and high success rate, PCI can …

[HTML][HTML] Efficacy and safety of drugs in residual cardiovascular risk: a systematic review of the literature

MA Hernandez-Sómerson, F Montoya-Agudelo… - International Journal of …, 2024 - Elsevier
Background The objective of this research is to evaluate the efficacy and safety of drugs in
the residual risk in any of its three components: lipid, inflammatory and thrombotic risk …

Association between endothelin-1, nitric oxide, and Gensini score in chronic coronary syndrome

Y Wang, Y Wang, T Liu, Y Qin, F Tang… - BMC Cardiovascular …, 2023 - Springer
Background Chronic coronary syndrome (CCS) is a major public health burden; its
pathogenesis involves atherosclerosis and endothelial dysfunction. Endothelin-1 (ET-1) and …

Quality by Design Approach Driven Development and Validation of Reverse Phase‐High‐Performance Liquid Chromatography Methodology for Dual Quantification of …

M Patel, H Patel, R Patel, U Shah… - Separation …, 2024 - Wiley Online Library
Clinical trials have shown that combining a modest dose of Rivaroxaban (RIV) with Aspirin
(ASP) is more effective than ASP alone in reducing cardiovascular mortality, myocardial …

[PDF][PDF] Development and application of HPTLC method for estimation of Rivaroxaban and Aspirin in bulk drug and in-house tablet form.

M Patel, K Bansal - Journal of Chemical Metrology, 2022 - researchgate.net
In the present work, simple, precise, accurate high-performance thin-layer chromatography
was developed, optimized, and validated for quantitation of Rivaroxaban (RIV) and Aspirin …

[引用][C] Efficacy and safety of acupuncture combined with Xuefu Zhuyu Decoction on major adverse cardiovascular events after percutaneous coronary intervention

MM Qingyuan Ma, MM Zhimei Cai, MM Lan Sui… - 2022 - europepmc.org
Background: Percutaneous coronary intervention (PCI) is an effective treatment for coronary
heart disease (CHD). With the merits of small trauma and high success rate, PCI can …